Cargando…

Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease

BACKGROUND: The role of hyperuricemia in disease progression of autosomal dominant polycystic kidney disease (ADPKD) has not been defined well. We investigated the association of serum uric acid (sUA) with renal function and the effect of hypouricemic treatment on the rate of renal function decline....

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Miyeun, Park, Hayne Cho, Kim, Hyunsuk, Jo, Hyung Ah, Huh, Hyuk, Jang, Joon Young, Kang, Ah-Young, Kim, Seung Hyup, Cheong, Hae Il, Kang, Duk-Hee, Yang, Jaeseok, Oh, Kook-Hwan, Hwang, Young-Hwan, Ahn, Curie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021172/ https://www.ncbi.nlm.nih.gov/pubmed/24739095 http://dx.doi.org/10.1186/1471-2369-15-63

Ejemplares similares

Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients
por: Park, Hayne Cho, et al.
Publicado: (2015)

Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease
por: Kim, Hyunsuk, et al.
Publicado: (2015)

Urinary N-acetyl-β-D glucosaminidase as a surrogate marker for renal function in autosomal dominant polycystic kidney disease: 1 year prospective cohort study
por: Park, Hayne Cho, et al.
Publicado: (2012)

Bioelectrical impedance analysis as a nutritional assessment tool in Autosomal Dominant Polycystic Kidney Disease
por: Ryu, Hyunjin, et al.
Publicado: (2019)

Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease
por: Hwang, Jin Ho, et al.
Publicado: (2013)

Xp11.2 translocation renal cell carcinoma in the autosomal dominant polycystic kidney disease patient with preserved renal function
por: Huh, Hyuk, et al.
Publicado: (2017)

Expression and secretion of CXCL12 are enhanced in autosomal dominant polycystic kidney disease
por: Kim, Hyunho, et al.
Publicado: (2019)

Successfully Treated Escherichia coli-Induced Emphysematous Cyst Infection with Combination of Intravenous Antibiotics and Intracystic Antibiotics Irrigation in a Patient with Autosomal Dominant Polycystic Kidney Disease
por: Kim, Hyunsuk, et al.
Publicado: (2013)

Total kidney and liver volume is a major risk factor for malnutrition in ambulatory patients with autosomal dominant polycystic kidney disease
por: Ryu, Hyunjin, et al.
Publicado: (2017)

Transcatheter Arterial Embolization Therapy for a Massive Polycystic Liver in Autosomal Dominant Polycystic Kidney Disease Patients
por: Park, Hayne Cho, et al.
Publicado: (2009)

Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease
por: Park, Hayne Cho, et al.
Publicado: (2020)

Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing
por: Kim, Hyunsuk, et al.
Publicado: (2019)

Author Correction: Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing
por: Kim, Hyunsuk, et al.
Publicado: (2020)

Factors Associated With the Development and Severity of Polycystic Liver in Patients With Autosomal Dominant Polycystic Kidney Disease
por: Kim, Yaerim, et al.
Publicado: (2023)

Identification of novel PKD1 and PKD2 mutations in Korean patients with autosomal dominant polycystic kidney disease
por: Choi, Rihwa, et al.
Publicado: (2014)

Clinical and genetic characteristics of Korean autosomal dominant polycystic kidney disease patients
por: Oh, Yun Kyu, et al.
Publicado: (2021)

Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period
por: Huh, Hyuk, et al.
Publicado: (2023)

Multiple Cardiovascular Manifestations in a Patient with Autosomal Dominant Polycystic Kidney Disease
por: Kang, Young Ran, et al.
Publicado: (2014)

Successful Pregnancy in a Patient with Autosomal Dominant Polycystic Kidney Disease on Long-Term Hemodialysis
por: Jung, Ji Hye, et al.
Publicado: (2014)

Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression
por: Kim, Hyunsuk, et al.
Publicado: (2022)

Esophageal Artery Pseudoaneurysm and Takayasu Arteritis in a Patient with Autosomal Dominant Polycystic Kidney Disease
por: Kim, Hyunsuk, et al.
Publicado: (2018)

Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study
por: Park, Hayne Cho, et al.
Publicado: (2022)

Synergistic Antiproliferative Effects of All-Trans Retinoic Acid and Paclitaxel on Autosomal Dominant Polycystic Kidney Disease Epithelial Cells
por: Nguyen, Que Thanh Thanh, et al.
Publicado: (2021)

Serum uric acid is associated with coronary artery calcification in early chronic kidney disease: a cross-sectional study
por: Han, Miyeun, et al.
Publicado: (2021)

Comprehensive analysis of mutations of renal cell carcinoma in an autosomal dominant polycystic kidney disease patient
por: Shim, Kwang Eon, et al.
Publicado: (2020)

Baseline General Characteristics of the Korean Chronic Kidney Disease: Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD)
por: Kang, Eunjeong, et al.
Publicado: (2017)

Obturator hernia in autosomal dominant polycystic kidney disease
por: Jung, Jong Hwan, et al.
Publicado: (2018)

Feasibility of artificial intelligence-based decision supporting system in tolvaptan prescription for autosomal dominant polycystic kidney disease
por: Shin, Jung Hyun, et al.
Publicado: (2023)

Safety and feasibility of synchronous unilateral nephrectomy and contralateral heminephrectomy for extremely severe autosomal dominant polycystic kidney disease: Techniques and outcome
por: Han, Jang Hee, et al.
Publicado: (2022)

A Case of Autosomal Dominant Osteopetrosis Type 2 with a CLCN7 Gene Mutation
por: Kang, Sol, et al.
Publicado: (2019)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study
por: Oh, Tae Ryom, et al.
Publicado: (2019)

Expert-level segmentation using deep learning for volumetry of polycystic kidney and liver
por: Shin, Tae Young, et al.
Publicado: (2020)

Cyst Ablation Using a Mixture of N-Butyl Cyanoacrylate and Iodized Oil in Patients with Autosomal Dominant Polycystic Kidney Disease: the Long-Term Results
por: Kim, See Hyung, et al.
Publicado: (2009)

Comparison of outcomes of chronic kidney disease based on etiology: a prospective cohort study from KNOW-CKD
por: Ryu, Hyunjin, et al.
Publicado: (2023)

Author Correction: Comparison of outcomes of chronic kidney disease based on etiology: a prospective cohort study from KNOW-CKD
por: Ryu, Hyunjin, et al.
Publicado: (2023)

Femoral Neuropathy Secondary to Autosomal Dominant Polycystic Kidney Disease: A Case Report
por: Yoo, Jeehyun, et al.
Publicado: (2018)

Fatal outcome of autosomal recessive polycystic kidney disease in neonates with recessive PKHD1 mutations
por: Jung, Jiwon, et al.
Publicado: (2020)

Metabolic acidosis is associated with pulse wave velocity in chronic kidney disease: Results from the KNOW-CKD Study
por: Kim, Hyo Jin, et al.
Publicado: (2019)

Autosomal dominant polycystic kidney disease in Colombia
por: Camargo, Jessica T., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sfaujpcsqsvslto33c1vb9l70t